Table 4. Sensitive analysis about MTHFR C677T and A1298C Polymorphism and VTE susceptibility.
| Comparison | Effect model | OR (95%CI) |
|---|---|---|
| MTHFR C677T | ||
| CC+CT vs TT | Random | 0.68 (0.56, 0.83) |
| Fixed | 0.80 (0.73, 0.87) | |
| CC vs CT+TT | Random | 0.82 (0.74, 0.93) |
| Fixed | 0.92 (0.87, 0.98) | |
| CC vs TT | Random | 0.65 (0.52, 0.81) |
| Fixed | 0.80 (0.73, 0.88) | |
| CT vs TT | Random | 0.73 (0.60, 0.89) |
| Fixed | 0.83 (0.75, 0.91) | |
| C vs T | Random | 0.80 (0.71, 0.90) |
| Fixed | 0.90 (0.87, 0.95) | |
| MTHFR A1298C | ||
| AA+AC vs CC | Random | 0.97 (0.71, 1.32) |
| Fixed | 0.99 (0.74, 1.33) | |
| AA vs AC+CC | Random | 0.91 (0.77, 1.08) |
| Fixed | 0.91 (0.77, 1.08) | |
| AA vs CC | Random | 0.90 (0.66, 1.23) |
| Fixed | 0.91 (0.67, 1.25) | |
| AC vs CC | Random | 1.01 (0.67, 1.52) |
| Fixed | 1.05 (0.77, 1.43) | |
| A vs C | Random | 0.95 (0.83, 1.07) |
| Fixed | 0.95 (0.83, 1.07) |
OR, odds ratio.